Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Quan Xiang

Showing results (91-100 of 94) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 94 results.
Journal of Natural Products|August 24, 2021
Indole Alkaloids from a Soil-Derived <i>Clonostachys rosea</i>Chun-Xiao Jiang, Bo Yu, Ya-Mei Miao, et al.
Journal of Natural Products|September 9, 2022
Correction to Indole Alkaloids from a Soil-Derived <i>Clonostachys rosea</i>Chun-Xiao Jiang, Bo Yu, Ya-Mei Miao, et al.
Blood|May 19, 2007
Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccinesNia Tatsis, Julie C Fitzgerald, Arturo Reyes-Sandoval, et al.
The Lancet. Microbe|July 30, 2022
Safety and immunogenicity of a simian-adenovirus-vectored rabies vaccine: an open-label, non-randomised, dose-escalation, first-in-human, single-centre, phase 1 clinical trialDaniel Jenkin, Adam J Ritchie, Jeremy Aboagye, et al.
Pageof 10

Showing results (91-100 of 94) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 94 results.
Journal of Natural Products|August 24, 2021
Indole Alkaloids from a Soil-Derived <i>Clonostachys rosea</i>Chun-Xiao Jiang, Bo Yu, Ya-Mei Miao, et al.
Journal of Natural Products|September 9, 2022
Correction to Indole Alkaloids from a Soil-Derived <i>Clonostachys rosea</i>Chun-Xiao Jiang, Bo Yu, Ya-Mei Miao, et al.
Blood|May 19, 2007
Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccinesNia Tatsis, Julie C Fitzgerald, Arturo Reyes-Sandoval, et al.
The Lancet. Microbe|July 30, 2022
Safety and immunogenicity of a simian-adenovirus-vectored rabies vaccine: an open-label, non-randomised, dose-escalation, first-in-human, single-centre, phase 1 clinical trialDaniel Jenkin, Adam J Ritchie, Jeremy Aboagye, et al.
Pageof 10